CMS is soliciting nominations for a total of 42 voting and nonvoting members of the Medicare Evidence Development & Coverage Advisory Committee (MedCAC), which advises CMS on the adequacy of scientific evidence available to CMS for Medicare “reasonable and necessary” determinations. Nominations must be received by September 24, 2012. CMS also is seeking nominations for
MedCAC
MedCAC to Review Coverage with Evidence Development Policy (May 16)
On May 16, 2012, the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) is holding a meeting on Evidentiary Characteristics for Coverage with Evidence Development, as part of CMS’s review of its policy on this issue.
MedCAC Meetings on Catheter Ablation, Lymphedema, Cancer Pharmacogenomic Testing, & ESA in Anemia Related to Kidney Disease
CMS has announced a series of Medicare Evidence Development & Coverage Advisory Committee (MedCAC) meetings to address specific Medicare coverage issues. MedCAC is meeting October 21, 2009 to focus on the use of catheter ablation for the treatment of atrial fibrillation. On November 18, 2009, MedCAC will address the adequacy of the available evidence…
MedCAC Nominations
On March 27, CMS published a notice soliciting nominations for membership on the Medicare Evidence Development & Coverage Advisory Committee (MedCAC), which advises the HHS Secretary on whether medical items and services are “reasonable and necessary” and therefore eligible for Medicare coverage. MedCAC is looking for experts in a number of area, with the most critical …
MedCAC Meeting on Medicare Coverage Evidence (June 17, 2009)
CMS has postponed until June 17, 2009 a Medicare Evidence Development & Coverage Advisory Committee (MedCAC) meeting on the use of Bayesian statistics to interpret evidence in making coverage decisions. Bayesian analysis is a statistical technique in which prior evidence is used to update or to newly infer the probability that a hypothesis may be true. CMS …